People who have chronic hepatitis B and active liver damage may benefit from telbivudine. This prescription medicine works by disrupting the multiplication process of the hepatitis B virus. Although it is not a cure, telbivudine can help slow down the spread of the virus and reduce damage to the liver. Side effects may include coughing, headaches, and fatigue.
Telbivudine (Tyzeka®) is a prescription medication approved to treat chronic hepatitis B infection in people age 16 and older with signs of liver damage. It is not a cure for hepatitis B, but it may reduce the amount of hepatitis B virus (HBV) in the body. Telbivudine belongs to a group of medications known as nucleoside reverse transcriptase inhibitors (NRTIs), which are sometimes simply called nucleoside analogues.
(Click What Is Telbivudine Used For? for more information on this topic, including possible off-label uses.)
Just like any medicine, telbivudine can cause side effects. However, not everyone who takes the drug will experience problems. In fact, most people tolerate it quite well.
If reactions do occur, in most cases, they are minor and either require no treatment or are treated easily by you or your healthcare provider. Serious side effects are less common.
Common side effects of telbivudine include but are not limited to:
(Click Telbivudine Side Effects to learn more, including potentially serious side effects you should report immediately to your healthcare provider.)